FDA seeks input on transparency with industry
This article was originally published in The Silver Sheet
Executive Summary
FDA is collecting information on ways to improve transparency with regulated industries - the third phase of its ongoing transparency initiative ("The Silver Sheet" December 2009). The agency is seeking public comment through April 12 on issues raised during listening sessions with industry in January. FDA is also gathering advice on how it can improve regulatory training and education for industry, guidance development, channels of communication with industry, and the timeliness and usefulness of its answers to industry questions
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.